
Opinion|Videos|June 12, 2024
Addressing Unmet Needs in the PAH Landscape
Author(s)Marius Hoeper, MD
Marius Hoeper, MD, describes the role clinicians can play in advocating for health care system reforms that could address the economic implications of PAH and discusses the key unmet needs in the PAH treatment landscape.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What role can clinicians play in advocating for integrated care delivery models, value-based payment strategies, or other health care system reforms that could address the economic implications of pulmonary arterial hypertension (PAH) more effectively?
- What are the key unmet needs or challenges related to the management of PAH that you hope will be addressed more comprehensively in the coming years as the treatment landscape evolves with therapies like sotatercept?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
ICER Draft Flags High Cost of New Hypertension Drug Class
2
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
3
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
4
What Comes After Anti-VEGF in Wet AMD: Arshad Khanani, MD
5




